查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1462768

到 2030 年无针注射系统市场预测：按产品、类型、技术、可用性、管理地点、应用、最终用户和地区进行全球分析

Needle-Free Injection System Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Usability, Site of Delivery, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球无针注射系统市场规模为 1.756 亿美元，预计预测期内复合年增长率为 19%，到 2030 年将达到 5.934 亿美元。

无针注射系统为传统注射提供了一个方便、无痛的替代方案。这项突破性技术利用高压迫使稀薄的液体溶液穿过皮肤，无需使用针头。此外，无针注射系统加快了医疗程序，同时透过精确剂量提高患者舒适度和依从性，并降低针头相关伤害和感染疾病的风险。

根据美国医学协会的说法，无针输液系统等医疗技术的进步对于透过提供创新的、侵入性较小的给药方法来改善患者护理至关重要。

无痛给药技术的需求

由于包括患者偏好在内的多种因素，无痛给药方法的需求量很大。对于老年和儿童患者尤其如此，他们可能会觉得传统的针头注射不舒服或有更大的焦虑。对疼痛的厌恶和对针头的恐惧症也增加了患者寻求替代给药方法的可能性。此外，无针注射系统的技术发展进一步刺激了对这些系统的需求，这些系统可确保无痛给药、提供精确的剂量控制、减少药物浪费的可能性并改善治疗效果。

成本和价格问题

无针输液系统可能会产生巨大的初始成本，包括购买耗材、培训医务人员以及与您目前的医疗保健设定整合。由于持续的维护、校准和消耗品成本，这些系统可能会给医疗机构带来财务挑战。此外，不同医疗保健系统之间的无针输液系统的覆盖范围和报销指南可能存在差异，这可能会影响患者的使用和负担能力。

扩大医疗应用

无针注射系统有很多机会将其治疗应用扩展到各种医学专业。人们对使用该技术提供生技药品、胜肽和创新治疗方法的兴趣正在增长，超越了胰岛素输送和疫苗接种等传统使用案例。配方科学、药物传输工程和微流体的进步使无针注射系统能够处理更广泛的药物，包括敏感的生物製药和高黏度配方。此外，治疗应用的普及不仅满足了未满足的临床需求，而且扩大了患者获得最先进治疗的机会，并为製造商创造了新的市场和收益来源。

市场饱和度与竞争格局

无针注射器市场的特点是竞争激烈，长期竞争对手和新进业者都在争夺市场占有率。随着技术的发展和广泛使用，市场可能会饱和状态，这可能会导致定价压力、商品化和报酬率下降。由于现有製造商相对于小型公司的竞争优势，例如广泛的研发能力和全球分销网络，新参与企业可能会发现很难进入市场。此外，替代药物传递技术（例如经皮吸收贴片、微针贴片和口服输送系统）的发展正在损害无针注射系统的优势。

COVID-19 的影响：

无针注射系统市场受到了 COVID-19 大流行的多方面影响。无针注射系统变得越来越受欢迎，因为它们提供了无针选项，可以降低针刺伤害和交叉污染的风险。一方面，人们对感染控制和最大限度地降低与医疗保健相关的感染相关的风险越来越感兴趣。疫情远端医疗凸显了对患者自我管理设备（例如无针注射系统）用于家庭治疗计划和虚拟就诊的需求。然而，供应链中断、经济不确定性以及集中资源应对 COVID-19 的决定正在导致选择性治疗和非必要医疗程序的延误。

春季细分市场预计将成为预测期内最大的细分市场

采用弹簧技术的无针注射系统占据最大的市场占有率。以弹簧为基础的系统不需要针头，利用压缩弹簧产生的机械力通过皮肤输送药物。这些系统因其价格实惠、可靠且易于使用而被广泛使用。精确的剂量控制、易于使用以及交叉污染和针刺伤害的低风险使其适合各种医疗应用，包括疫苗接种、胰岛素给药和荷尔蒙疗法。此外，弹簧加载的无针注射系统易于使用，适合患者在家中和诊所自行给药。

预计肿瘤学在预测期内将经历最高的复合年增长率。

肿瘤学领域预计将在无针注射系统市场中拥有最高的复合年增长率。在肿瘤学领域，无针注射系统用于实施各种癌症治疗，包括免疫疗法、标靶治疗和化疗药物。此外，推动这一增长的主要因素是全球癌症发病率上升、对患者友好且高效的药物输送系统的需求以及改进的癌症治疗选择。对于癌症患者来说，无针注射系统具有许多好处，包括减轻疼痛、更好地坚持治疗以及提高药物传递的精确度。

比例最高的地区：

北美占据无针注射器市场的最大份额。这一优势得益于发达的医疗基础设施、高昂的医疗支出、完善的法规环境以及较早采用尖端医疗技术。此外，研发支出的增加、糖尿病和癌症等慢性病盛行率的增加以及公众对感染控製程序和针刺伤的认识的提高也推动了市场的成长。此外，无针注射系统在北美临床应用中的广泛使用归因于主要行业参与者的策略行动、製药和设备製造商之间的联盟以及有利的报销政策。

复合年增长率最高的地区：

对于无针注射器市场，亚太地区预计将以最高的复合年增长率成长。造成这种增长的因素有很多，包括医疗保健成本上升、医疗保健服务范围扩大、尖端医疗技术的使用增加以及公众对无针注射系统好处的认识提高。此外，由于人口众多，尤其是中国和印度，该地区的无针注射系统製造商有许多市场机会。此外，由于医疗保健基础设施的改善、监管变化以及研发支出等努力，亚太市场正在不断成长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球无针注射系统市场：按产品

  • 可填充无针注射器
  • 预填充无针注射器
  • 其他产品

第六章全球无针注射系统市场：按类型

  • 液基无针注射器
  • 基于弹丸/仓库的无针注射器
  • 粉红基无针注射器
  • 其他类型

第七章全球无针注射系统市场：依技术分类

  • 弹簧底座
  • 汽油动力
  • 雷射驱动
  • 振动底座
  • 其他技术

第八章全球无针注射系统市场：按可用性

  • 一次性无针注射器
  • 可重复使用的无针注射器

第九章全球无针注射系统市场：依管理地点分类

  • 皮下注射器
  • 肌内注射器
  • 皮内注射器

第十章全球无针注射系统市场：依应用分类

  • 疫苗递送
  • 胰岛素给药
  • 肿瘤学
  • 疼痛管理
  • 皮肤科
  • 其他用途

第十一章全球无针注射系统市场：依最终用户分类

  • 医院和诊所
  • 居家照护环境
  • 研究实验室
  • 製药和生物技术公司
  • 其他最终用户

第十二章全球无针注射系统市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十三章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十四章 公司概况

  • Ferring BV
  • INVIO Pharmaceutical Inc
  • Bioject Medical Technologies
  • Medical International Technology, Inc
  • PharmaJet
  • 3M
  • Portal Instruments
  • NovaXS Biotech
  • Enesi Pharma Limited
  • Antares Pharma
  • NuGen Medical Devices
  • Crossject SA
  • Injex Pharma AG
Product Code: SMRC25819

According to Stratistics MRC, the Global Needle-Free Injection System Market is accounted for $175.60 million in 2023 and is expected to reach $593.40 million by 2030 growing at a CAGR of 19% during the forecast period. The administration of medications is revolutionized by a needle-free injection system, which provides a convenient and painless substitute for traditional injections. This ground-breaking technology does away with the need for needles by using high pressure to push a thin stream of medication through the skin. Moreover, needle-free injection systems expedite medical procedures while improving patient comfort and compliance through accurate dosage delivery and a decreased risk of needle-related injuries or infections.

According to the American Medical Association, Advancements in medical technology, such as Needle-Free Injection Systems, are crucial in improving patient care by offering innovative and less invasive methods of medication delivery.

Market Dynamics:

Driver:

Demand for painless medication delivery techniques

Painless drug delivery methods are in demand due to a number of factors, including patient preferences. This is particularly true for older and pediatric populations, who may find traditional needle injections to be uncomfortable or cause them more anxiety. Aversion to pain or needle phobia also increases the likelihood that a patient will look for alternate delivery methods. Furthermore, the need for these systems is being further stimulated by technological developments in needle-free injection systems, which guarantee painless administration and provide accurate dosage control, lowering the possibility of medication waste and improving therapeutic performance.

Restraint:

Cost consequences and issues with affordability

Needle-free injection systems can come with a hefty upfront cost, which includes purchasing supplies, educating medical staff, and integrating the system with the current healthcare setup. These systems may present financial difficulties for healthcare facilities due to their ongoing maintenance, calibration, and consumable costs, especially in resource-constrained environments or areas with tight healthcare budgets. Additionally, there may be differences in the coverage and reimbursement guidelines for needle-free injection systems among various healthcare systems, which could affect patients' access to and affordability.

Opportunity:

Extension of medicinal uses

There are a lot of opportunities for expanding therapeutic applications across different medical specialties with needle-free injection systems. Interest in using this technology to administer biologics, peptides, and innovative treatments is growing beyond traditional use cases like insulin delivery and vaccinations. Advances in formulation science, drug delivery engineering, and microfluidics have made it possible for needle-free injection systems to handle a wider variety of drugs, including sensitive biopharmaceuticals and high-viscosity formulations. Moreover, the proliferation of therapeutic applications not only fills unmet clinical needs but also expands patient access to cutting-edge treatments and creates new markets and revenue streams for manufacturers.

Threat:

Market saturation and competitive landscape

The market for needle-free injection systems is characterized by fierce competition between long-standing competitors and recent entries vying for market share. The market may get more saturated as the technology develops and becomes more widely used, which could result in price pressure, commoditization, and a decline in profit margins. New entrants may find it difficult to break into the market due to established manufacturer's competitive advantage over smaller businesses, which includes extensive R&D capabilities and global distribution networks. Furthermore, the dominance of needle-free injection systems is in jeopardy due to the development of alternative drug delivery technologies like transdermal patches, microneedle patches, and oral delivery systems.

Covid-19 Impact:

The market for needle-free injection systems has seen differing effects from the COVID-19 pandemic. Needle-free injection systems have become more popular because they provide a needle-free option that lowers the risk of needlestick injuries and cross-contamination. On the one hand, this is due to the increased focus on infection control and minimizing risks associated with healthcare-associated transmission. The necessity of patient self-administration devices, such as needle-free injection systems, for at-home treatment plans and virtual consultations has been highlighted by the pandemic's shift towards telemedicine and remote healthcare delivery models. However, delays in elective treatments and non-essential medical procedures have been caused by supply chain disruptions, economic uncertainty, and the decision to focus resources on COVID-19 response efforts.

The Spring-based segment is expected to be the largest during the forecast period

The needle-free injection system with spring technology commands the largest market share. Without the need for needles, spring-based systems deliver drugs through the skin using the mechanical force produced by a compressed spring. Because of these systems' affordability, dependability, and ease of use, they are extensively used. They are appropriate for a variety of medical applications, such as vaccinations, insulin delivery, and hormone therapy; because they provide accurate dosage control, ease of use, and a low risk of cross-contamination or needlestick injuries. Additionally, spring-based needle-free injection systems are easy to use, which makes them appropriate for patient self-administration in both home and clinical settings.

The Oncology segment is expected to have the highest CAGR during the forecast period

In the market for needle-free injection systems, the oncology segment is anticipated to have the highest CAGR. In the oncology segment, needle-free injection systems are used to administer different cancer therapeutics, such as immunotherapies, targeted therapies, and chemotherapy medications. Moreover, the primary factors driving this growth are the rising global incidence of cancer, the need for more patient-friendly and efficient drug delivery systems, and improvements in cancer treatment options. For cancer patients, needle-free injection systems provide a number of benefits, including decreased pain, better adherence to treatment, and increased accuracy in drug delivery-all of which are critical for maximizing therapeutic results and minimizing side effects.

Region with largest share:

In the market for needle-free injection systems, North America has the largest share. The presence of a well-established healthcare infrastructure, high healthcare spending, a strong regulatory environment, and early adoption of cutting-edge medical technologies are some of the factors that are credited with this dominance. Growth in the market is also fueled by rising spending on R&D, an increase in the prevalence of chronic illnesses like diabetes and cancer, and increased public awareness of infection control procedures and needlestick injuries. Additionally, the extensive use of needle-free injection systems in North America's clinical applications can be attributed to the strategic actions taken by major industry participants, partnerships between drug companies and device manufacturers, and advantageous reimbursement policies.

Region with highest CAGR:

In the market for needle-free injection systems, Asia Pacific is anticipated to grow at the highest CAGR. Numerous factors are contributing to this growth, such as rising healthcare costs, greater access to healthcare services, increased use of cutting-edge medical technologies, and rising public awareness of the advantages of needle-free injection systems. Furthermore, there are a lot of market opportunities for Needle-Free Injection System manufacturers in the region due to the large population base, especially in China and India. The Asia Pacific market is also growing as a result of efforts to improve the infrastructure for healthcare, regulatory changes, and R&D spending.

Key players in the market

Some of the key players in Needle-Free Injection System market include Ferring B.V, INVIO Pharmaceutical Inc, Bioject Medical Technologies, Medical International Technology, Inc, PharmaJet, 3M, Portal Instruments, NovaXS Biotech, Enesi Pharma Limited, Antares Pharma, NuGen Medical Devices, Crossject SA and Injex Pharma AG.

Key Developments:

In January 2024, INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, announced a clinical collaboration and supply agreement with Coherus BioSciences, Inc. to evaluate the combination of INO-3112 and LOQTORZI(TM) as a potential treatment for patients with locoregionally advanced, high-risk, HPV16/18 positive oropharyngeal squamous cell carcinoma (OPSCC), a type of head and neck cancer commonly known as throat cancer.

In May 2023, 3M is expanding its ongoing commitment to materials science-based climate tech solutions by working with Svante Technologies, Inc. (Svante) to develop material that can trap carbon dioxide (CO2) found in the atmosphere and permanently remove it.

In December 2023, NuGen Medical Devices Inc. a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, as of December 12, 2023, Advance Medical Life Co. Ltd., a limited liability company domiciled in Bangkok, Thailand, became the exclusive distributor for NuGen's needle-free InsuJet(TM) device aimed at improving the delivery of care and life for millions of diabetics worldwide. InsuJet(TM) is approved for sale in Thailand as a medical device.

Products Covered:

  • Fillable Needle-free Injectors
  • Prefilled Needle-free Injectors
  • Other Products

Types Covered:

  • Liquid-based Needle-free Injectors
  • Projectile/Depot-based Needle-free Injectors
  • Powder-based Needle-free Injectors
  • Other Types

Technologies Covered:

  • Spring-based
  • Gas-powered
  • Laser-powered
  • Vibration-based
  • Other Technologies

Usabilities Covered:

  • Disposable Needle-free Injectors
  • Reusable Needle-free Injectors

Site of Deliveries Covered:

  • Subcutaneous Injectors
  • Intramuscular Injectors
  • Intra Dermal Injectors

Applications Covered:

  • Vaccine Delivery
  • Insulin Delivery
  • Oncology
  • Pain Management
  • Dermatology
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Home Care Settings
  • Research Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Needle-Free Injection System Market, By Product

  • 5.1 Introduction
  • 5.2 Fillable Needle-free Injectors
  • 5.3 Prefilled Needle-free Injectors
  • 5.4 Other Products

6 Global Needle-Free Injection System Market, By Type

  • 6.1 Introduction
  • 6.2 Liquid-based Needle-free Injectors
  • 6.3 Projectile/Depot-based Needle-free Injectors
  • 6.4 Powder-based Needle-free Injectors
  • 6.5 Other Types

7 Global Needle-Free Injection System Market, By Technology

  • 7.1 Introduction
  • 7.2 Spring-based
  • 7.3 Gas-powered
  • 7.4 Laser-powered
  • 7.5 Vibration-based
  • 7.6 Other Technologies

8 Global Needle-Free Injection System Market, By Usability

  • 8.1 Introduction
  • 8.2 Disposable Needle-free Injectors
  • 8.3 Reusable Needle-free Injectors

9 Global Needle-Free Injection System Market, By Site of Delivery

  • 9.1 Introduction
  • 9.2 Subcutaneous Injectors
  • 9.3 Intramuscular Injectors
  • 9.4 Intra Dermal Injectors

10 Global Needle-Free Injection System Market, By Application

  • 10.1 Introduction
  • 10.2 Vaccine Delivery
  • 10.3 Insulin Delivery
  • 10.4 Oncology
  • 10.5 Pain Management
  • 10.6 Dermatology
  • 10.7 Other Applications

11 Global Needle-Free Injection System Market, By End User

  • 11.1 Introduction
  • 11.2 Hospitals and Clinics
  • 11.3 Home Care Settings
  • 11.4 Research Laboratories
  • 11.5 Pharmaceutical and Biotechnological Companies
  • 11.6 Other End Users

12 Global Needle-Free Injection System Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Ferring B.V
  • 14.2 INVIO Pharmaceutical Inc
  • 14.3 Bioject Medical Technologies
  • 14.4 Medical International Technology, Inc
  • 14.5 PharmaJet
  • 14.6 3M
  • 14.7 Portal Instruments
  • 14.8 NovaXS Biotech
  • 14.9 Enesi Pharma Limited
  • 14.10 Antares Pharma
  • 14.11 NuGen Medical Devices
  • 14.12 Crossject SA
  • 14.13 Injex Pharma AG

List of Tables

  • Table 1 Global Needle-Free Injection System Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Needle-Free Injection System Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Needle-Free Injection System Market Outlook, By Fillable Needle-free Injectors (2021-2030) ($MN)
  • Table 4 Global Needle-Free Injection System Market Outlook, By Prefilled Needle-free Injectors (2021-2030) ($MN)
  • Table 5 Global Needle-Free Injection System Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Needle-Free Injection System Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Needle-Free Injection System Market Outlook, By Liquid-based Needle-free Injectors (2021-2030) ($MN)
  • Table 8 Global Needle-Free Injection System Market Outlook, By Projectile/Depot-based Needle-free Injectors (2021-2030) ($MN)
  • Table 9 Global Needle-Free Injection System Market Outlook, By Powder-based Needle-free Injectors (2021-2030) ($MN)
  • Table 10 Global Needle-Free Injection System Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 11 Global Needle-Free Injection System Market Outlook, By Technology (2021-2030) ($MN)
  • Table 12 Global Needle-Free Injection System Market Outlook, By Spring-based (2021-2030) ($MN)
  • Table 13 Global Needle-Free Injection System Market Outlook, By Gas-powered (2021-2030) ($MN)
  • Table 14 Global Needle-Free Injection System Market Outlook, By Laser-powered (2021-2030) ($MN)
  • Table 15 Global Needle-Free Injection System Market Outlook, By Vibration-based (2021-2030) ($MN)
  • Table 16 Global Needle-Free Injection System Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 17 Global Needle-Free Injection System Market Outlook, By Usability (2021-2030) ($MN)
  • Table 18 Global Needle-Free Injection System Market Outlook, By Disposable Needle-free Injectors (2021-2030) ($MN)
  • Table 19 Global Needle-Free Injection System Market Outlook, By Reusable Needle-free Injectors (2021-2030) ($MN)
  • Table 20 Global Needle-Free Injection System Market Outlook, By Site of Delivery (2021-2030) ($MN)
  • Table 21 Global Needle-Free Injection System Market Outlook, By Subcutaneous Injectors (2021-2030) ($MN)
  • Table 22 Global Needle-Free Injection System Market Outlook, By Intramuscular Injectors (2021-2030) ($MN)
  • Table 23 Global Needle-Free Injection System Market Outlook, By Intra Dermal Injectors (2021-2030) ($MN)
  • Table 24 Global Needle-Free Injection System Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 Global Needle-Free Injection System Market Outlook, By Vaccine Delivery (2021-2030) ($MN)
  • Table 26 Global Needle-Free Injection System Market Outlook, By Insulin Delivery (2021-2030) ($MN)
  • Table 27 Global Needle-Free Injection System Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 28 Global Needle-Free Injection System Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 29 Global Needle-Free Injection System Market Outlook, By Dermatology (2021-2030) ($MN)
  • Table 30 Global Needle-Free Injection System Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Global Needle-Free Injection System Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 Global Needle-Free Injection System Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 33 Global Needle-Free Injection System Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 34 Global Needle-Free Injection System Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 35 Global Needle-Free Injection System Market Outlook, By Pharmaceutical and Biotechnological Companies (2021-2030) ($MN)
  • Table 36 Global Needle-Free Injection System Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.